
The Portuguese antitrust authority has initiated proceedings against two subsidiaries of laboratory specialist Synlab.
In the room are possible violations between 2016 and March 2022 against competition law, as the SDax-listed company announced on Wednesday after the stock market closed in Munich.
In addition to Synlab, other medical diagnostics providers operating in Portugal and an industry association are involved, it said.
No further details were provided. The group could not comment on the outcome of the proceedings or the risk of a possible fine before this review was completed, it said.
Featured News
Meta’s $220 Million Fine in Nigeria Upheld by Competition Tribunal
Apr 27, 2025 by
CPI
DoorDash Proposes $3.6 Billion Acquisition of Deliveroo
Apr 27, 2025 by
CPI
US Judge Delays Approval of $2.8 Billion NCAA Settlement Over Athlete Rights
Apr 27, 2025 by
CPI
US Launches Criminal Antitrust Probe Into TP-Link’s Pricing Practices
Apr 27, 2025 by
CPI
CK Hutchison’s $22.8 Billion Port Sale to BlackRock Draws Chinese Scrutiny
Apr 27, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Mergers in Digital Markets
Apr 21, 2025 by
CPI
Catching a Killer? Six “Genetic Markers” to Assess Nascent Competitor Acquisitions
Apr 21, 2025 by
John Taladay & Christine Ryu-Naya
Digital Decoded: Is There More Scope for Digital Mergers In 2025?
Apr 21, 2025 by
Colin Raftery, Michele Davis, Sarah Jensen & Martin Dickson
AI In the Mix – An Ever-Evolving Approach to Jurisdiction Over Digital Mergers in Europe
Apr 21, 2025 by
Ingrid Vandenborre & Ketevan Zukakishvili
Antitrust Enforcement Errors Due to a Failure to Understand Organizational Capabilities and Dynamic Competition
Apr 21, 2025 by
Magdalena Kuyterink & David J. Teece